Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 3OTHER_GOV 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Pleural Effusion, Malignant 3Neoplasm Metastasis 2

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Talc × Clear all
NCT02674243 2020-01-23

Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion

Chiang Mai University

Phase 3 Completed
60 enrolled
Thoracic

Pleural Effusion, Malignant

NCT00042770 2016-07-04

Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
67 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

NCT00002622 2016-06-28

Talc in Treating Patients With Malignant Pleural Effusion

Alliance for Clinical Trials in Oncology

Phase 3 Completed
501 enrolled
Thoracic

Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡